Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCat cells

Experimental Cell Research

Volumn 274, Issue 1, 2002, Pages 130-137

  Boudjelal, Mohamed ^a   Voorhees, John J ^a   Fisher, Gary J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Proteasome; RAR ; Retinoids; RXR

Indexed keywords

ALITRETINOIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; MUTANT PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEASOME; PROTEIN; RECEPTOR INTERACTING PROTEIN 140; RETINOIC ACID; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOID X RECEPTOR; SILENCING MEDIATOR FOR RETINOIC ACID RECEPTOR AND THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DISSOCIATION; GENE EXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; KERATINOCYTE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0036346133     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5450     Document Type: Article

References (33)

1. Cellular, immunologic and biochemical characterization of topical retinoic-acid treated human skin
2. Synthetic retinoids in dermatology
3. A decade of molecular biology of retinoic acid receptors
4. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin
5. A transcriptional corepressor that interacts with nuclear hormone receptors
6. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
7. Nuclear hormone receptor co-activators and co-repressors
8. Mechanism of corepressor binding and release from nuclear hormone receptors
9. Molecular determinants of nuclear receptor/corepressor interaction
10. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
11. SMRT silencing mediator of retinoid and thyroid receptor
12. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARα) and oncogenic RARα fusion proteins
13. 9-cis-Retinoic acid decreases the level of its cognate receptor, retinoid X receptor, through acceleration of the turnover
14. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor-γ and retinoids X receptor-α in human keratinocytes
15. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin
16. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment
17. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation
18. Mechanistic studies on the inactivation of the proteasome by lactacystin: A central role for clasto-lactacystin β-lactone
19. All-trans and 9-cis retinoic acid induction of CRABP-II transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs
20. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids
21. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells
22. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha
23. Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells, and hairless mouse skin in vivo
24. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta
25. The ubiquitin-proteasome proteolytic pathway
26. Ubiquitin-dependent protein degradation
27. Ubiquitin and intracellular protein degradation
28. Dimerization with retinoid X receptors and phosphoylation modulate the retinoic acid-induced degradation of retinoic acid receotirs alpha and gamma through the ubiquitin-proteasome pathway
29. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors α and γ through proteasomes in MCF-7 human breast cancer cells
30. Cleavage of RXRα by a lysosomal enzyme, cathepsin L-type protease
31. Proteasome-dependent degradation of the human estrogen receptor
32. The human estrogen receptor-α is a ubiquitated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators